| Pneumovax 23 (23-valent pneumococcal polysaccharide) / Merck (MSD) |
NCT00304382: Humoral Determinants of Immunity to Pneumococcal Infection |
|
|
| Completed | 4 | 114 | US | Prevnar, Pneumococcal 7-Valent Conjugate Vaccine, Pneumovax, Pneumococcal Vaccine Polyvalent | VA Office of Research and Development, Michael E. DeBakey VA Medical Center | Pneumonia, Pneumococcal Infections, Infections, Streptococcus Pneumoniae | 09/06 | 06/12 | | |
| Completed | 4 | 42 | Europe | Pneumococcal polysaccharide vaccine, Pneumovax, pneumococcal conjugate vaccine, Prevenar | Helsinki University Central Hospital | Pneumococcal Pneumonia | 06/10 | 06/10 | | |
| Completed | 4 | 56 | RoW | Zinc, Zinc sulfate, Sucrose, Sucrose syrup, PCV Vaccine, Prevenar 13®, PPV Vaccine, Pneumovax® | Fakultas Kedokteran Universitas Indonesia | Thalassemia, Pneumococcal Infection | 02/14 | 02/14 | | |
NCT02260882: Revaccination With PNEUMOVAX™ 23 in Older Japanese Adults (V110-902) |
|
|
| Completed | 4 | 243 | NA | PNEUMOVAX™ 23 | Merck Sharp & Dohme LLC | Pneumococcal Infection | 04/15 | 04/15 | | |
NCT02592486: The Immunogenicity of Simultaneous Administration of Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Vaccine |
|
|
| Completed | 4 | 162 | Japan | Simultaneous administration of Pneumovax NP® and Fluvic HA syringe®, Pneumovax NP® and Fluvic HA syringe®, Sequential administration of Pneumovax NP® and Fluvic HA syringe® | Kameda Medical Center, PPD, Osaka University, Merck Sharp & Dohme LLC | Pneumococcal Pneumonia, Influenza | 03/16 | 08/16 | | |
